Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis
出版年份 2022 全文链接
标题
Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis
作者
关键词
-
出版物
Frontiers in Oncology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-07-01
DOI
10.3389/fonc.2022.929996
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anticancer activity of Neosetophomone B by targeting AKT/SKP2/MTH1 axis in leukemic cells
- (2022) Shilpa Kuttikrishnan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Thiostrepton inhibits growth and induces apoptosis by targeting FoxM1/SKP2/MTH1 axis in B-precursor acute lymphoblastic leukemia cells
- (2021) Shilpa Kuttikrishnan et al. LEUKEMIA & LYMPHOMA
- Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway
- (2020) Abdul Q. Khan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent progress in TGF-β inhibitors for cancer therapy
- (2020) Cheng-Yi Huang et al. BIOMEDICINE & PHARMACOTHERAPY
- Meroterpenoids from Neosetophoma sp.: A Dioxa[4.3.3]propellane Ring System, Potent Cytotoxicity, and Prolific Expression
- (2019) Tamam El-Elimat et al. ORGANIC LETTERS
- Shikonin derivatives for cancer prevention and therapy
- (2019) Joelle C. Boulos et al. CANCER LETTERS
- High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma
- (2019) Junjie Piao et al. GENE
- Alkaloids for cancer prevention and therapy: Current progress and future perspectives
- (2019) Arijit Mondal et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
- (2019) Katie L. Owen et al. Cancers
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma
- (2017) Qing Ma et al. ONCOLOGY REPORTS
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Acute Myeloid Leukemia, Version 2.2013
- (2017) Margaret R. O’Donnell et al. Journal of the National Comprehensive Cancer Network
- Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
- (2016) Wei-de Zhong et al. OncoTargets and Therapy
- Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells
- (2015) Maqbool Ahmed et al. Molecular Cancer
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Identification of FoxM1/Bub1b Signaling Pathway as a Required Component for Growth and Survival of Rhabdomyosarcoma
- (2012) X. Wan et al. CANCER RESEARCH
- The dual PI3K/mTOR inhibitor NVP-BEZ235 and chloroquine synergize to trigger apoptosisviamitochondrial-lysosomal cross-talk
- (2012) Christian Seitz et al. INTERNATIONAL JOURNAL OF CANCER
- The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
- (2012) L J Monteiro et al. ONCOGENE
- Negative Feedback and Adaptive Resistance to the Targeted Therapy of Cancer
- (2012) Sarat Chandarlapaty Cancer Discovery
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation
- (2011) Robin M. Ricke et al. JOURNAL OF CELL BIOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma
- (2010) David M. Lucas et al. CURRENT DRUG TARGETS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started